American Bailey Ventures
5
15M
2
0.60
2
- Stages of investment
- Areas of investment
Summary
The leading representative office of defined VC is situated in the Stamford. The fund was located in North America if to be more exact in United States.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2011. This American Bailey Ventures works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2004. The fund is constantly included in less than 2 deals per year.
We can highlight the next thriving fund investment areas, such as Software, Pharmaceutical. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Atlantis Components, Endocyte For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the American Bailey Ventures, startups are often financed by Sanderling Ventures, Triathlon Medical Venture Partners, Burrill & Company. The meaningful sponsors for the fund in investment in the same round are Sanderling Ventures, Triathlon Medical Venture Partners, Burrill & Company. In the next rounds fund is usually obtained by Triathlon Medical Venture Partners, Sanderling Ventures, Burrill & Company.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 0
- Exits
- 2
- Follow on index
- 0.60
- Investments by industry
- Pharmaceutical (3)
- Biotechnology (3)
- Health Care (3)
- Dental (2)
- Software (2)
- Investments by region
-
- United States (5)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 25
- Group Appearance index
- 1.00
- Avg. company exit year
- 16
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Endocyte | 19 Jan 2010 | Biotechnology, Health Care, Pharmaceutical | Late Stage Venture | 26M | United States, Indiana |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.